Special Issue "Biomimetic Nanomaterials"
Deadline for manuscript submissions: 18 December 2021.
Interests: synthetic biology; biotechnology; nanoscience; bioinformatics; regenerative medicine; biocatalysis
Interests: biomimetic materials; nanocarriers for drug delivery; gene therapy; tissue engineering; regenerative medicine; organoid based drug evaluation
Interests: biomimetic nanomaterials and nanomedicine; peptide-based drug design; biomacromolecular drugs and targeted delivery; advanced anticancer theranostics, polymeric hydrogels and tissue engineering
The past five decades have seen studies in biology, biotechnology, pharmacology and medicine focusing on genetic and epigenetic determinants and, in the most recent years, the overall approach has moved towards a genome/proteome-wide scale. However, it has become more and more evident that both micro and macro environmental signals play a pivotal role in co-regulating cell fate and differentiation, tissue and organ development, thus being involved in physiological pathways and—when impaired—in the mechanisms underlying diseases. Cells are able to sense the nano-topographical features of the substrate they are growing in/on, and a huge number of biochemical cues are involved in the fine-tuning of their differentiation and migration. Tissue development and shaping are driven—in addition to genetic signals—by a complex environmental code consisting of attractive/repulsive interactions leading to signaling cascades and cross-talk. Therefore, developing biomimetic signals is of great help in both (i) basic science studies aimed at elucidating, by fine dissection of motifs and functions, molecular and cellular pathways; and (ii) applied science projects providing humans with enhanced tools for theranostics and drug delivery, regenerative medicine and vaccine development, bioremediation and green chemistry. Nanomaterials are the elective starting point for biomimetics because of their nano-scale and evidence that they can be combined in various formulations to improve and better mimic natural features, providing the scientists with reliable tools for synthetic biology and nanotechnology approaches to basic and translational research.
This Special Issue will attempt to cover recent advances in the design and use of biomimetic nanomaterials in multiple fields of application, e.g. the development of biomimetic scaffolds for regenerative medicine, nanomaterial-based biosensors and antimicrobials, biomimetic nanoparticle vaccines and nano-carriers for drug delivery, including front-end approaches to bioremediation and green chemistry. We welcome submissions of both original research papers and reviews on this topic.
Prof. Dr. Francesco Filippini
Prof. Dr. Xiangdong Kong
Prof. Dr. Xianghui Xu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- biomimetic scaffolds and regenerative medicine
- biomimetic nano-carriers and drug delivery
- biomimetic materials in theranostics
- nanomaterial-based biosensors
- nanomaterials and bioimaging
- antimicrobial nanomaterials
- biomimetic nanoparticle vaccines
- nanomaterials and biocatalysis